Biosynex SA
PAR:ALBIO

Watchlist Manager
Biosynex SA Logo
Biosynex SA
PAR:ALBIO
Watchlist
Price: 2.9 EUR -3.17% Market Closed
Market Cap: 31.2m EUR
Have any thoughts about
Biosynex SA?
Write Note

Biosynex SA
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Biosynex SA
Cost of Revenue Peer Comparison

Comparables:
EDAP
BIM
ALCAR
ALVMG
AMPLI

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Biosynex SA
PAR:ALBIO
Cost of Revenue
-€43.8m
CAGR 3-Years
20%
CAGR 5-Years
-24%
CAGR 10-Years
-60%
Edap Tms SA
NASDAQ:EDAP
Cost of Revenue
-€36m
CAGR 3-Years
-16%
CAGR 5-Years
-10%
CAGR 10-Years
-9%
Biomerieux SA
PAR:BIM
Cost of Revenue
-€1.7B
CAGR 3-Years
-7%
CAGR 5-Years
-8%
CAGR 10-Years
-8%
Carmat SA
PAR:ALCAR
Cost of Revenue
-€35.1m
CAGR 3-Years
-4%
CAGR 5-Years
-1%
CAGR 10-Years
-8%
Visiomed Group SA
PAR:ALVMG
Cost of Revenue
-€789k
CAGR 3-Years
64%
CAGR 5-Years
30%
CAGR 10-Years
17%
Amplitude Surgical SA
PAR:AMPLI
Cost of Revenue
-€37.9m
CAGR 3-Years
5%
CAGR 5-Years
5%
CAGR 10-Years
N/A

See Also

What is Biosynex SA's Cost of Revenue?
Cost of Revenue
-43.8m EUR

Based on the financial report for Dec 31, 2023, Biosynex SA's Cost of Revenue amounts to -43.8m EUR.

What is Biosynex SA's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-60%

Over the last year, the Cost of Revenue growth was 54%. The average annual Cost of Revenue growth rates for Biosynex SA have been 20% over the past three years , -24% over the past five years , and -60% over the past ten years .

Back to Top